Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Quest Diagnostics (NY:DGX)

193.67 +0.51 (+0.26%)
Official Closing Price Updated: 6:30 PM EDT, Jun 3, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Quest Diagnostics

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
News headline image
3 Reasons to Sell DGX and 1 Stock to Buy Instead
Since November 2025, Quest has been in a holding pattern, posting a small return of 2.6% while floating around $194.06. The stock also fell short of the S&P ... 
Via StockStory
Topics Stocks
News headline image
1 Profitable Stock to Own for Decades and 2 We Avoid
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does... 
Via StockStory
Quest Diagnostics (NYSE:DGX): A Solid Dividend Play Backed by Strong Profitability and Financial Health ↗
Via Chartmill
News headline image
2026 Market Cap Madness Championship: Loren v. Emily ↗
It’s time to crown a winner: defending champion Emily Flippen faces off against Cinderella challenger Loren Horst in the Market Cap Madness World Championship. 
Via The Motley Fool
Quest Diagnostics Inc (NYSE:DGX) Beats Q1 2026 Estimates and Raises Full-Year Guidance ↗
Via Chartmill
Quest Diagnostics Inc. (NYSE:DGX) Stands Out as a Sustainable Dividend Stock ↗
Via Chartmill
News headline image
5 Must-Read Analyst Questions From Quest’s Q1 Earnings Call
Quest Diagnostics delivered first quarter results that exceeded Wall Street’s revenue and profit expectations, driven by broad-based demand for its clinical ... 
Via StockStory
Topics Artificial Intelligence Earnings
News headline image
DGX Q1 Deep Dive: Organic Growth, Consumer Testing Momentum, and Advanced Diagnostics Drive Outlook
Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 9.2% year on ... 
Via StockStory
Topics Artificial Intelligence
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
Quest (DGX) Q1 2026 Earnings Transcript ↗
Quest (DGX) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Artificial Intelligence
Top S&P500 movers in Tuesday's session ↗
Via Chartmill
News headline image
Quest (DGX) Q4 2024 Earnings Transcript ↗
Quest (DGX) Q4 2024 Earnings Transcript 
Via The Motley Fool
News headline image
Quest (DGX) Q1 2025 Earnings Transcript ↗
Quest (DGX) Q1 2025 Earnings Transcript 
Via The Motley Fool
Which S&P500 stocks are gapping on Tuesday? ↗
Via Chartmill
Wondering what's happening in today's S&P500 pre-market session? ↗
Via Chartmill
News headline image
Quest’s (NYSE:DGX) Q1 CY2026 Sales Beat Estimates
Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q1 CY2026 results beating Wall Street’s revenue expectations, with sales up 9.2% year on... 
Via StockStory
Topics Earnings
News headline image
Quest (DGX) To Report Earnings Tomorrow: Here Is What To Expect
Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) will be reporting results this Tuesday before market open. Here’s what investors should know. Que... 
Via StockStory
Topics Artificial Intelligence
News headline image
2 S&P 500 Stocks Worth Your Attention and 1 We Ignore
The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning. Some companies face significant ch... 
Via StockStory
Topics Stocks
News headline image
Q4 Earnings Roundup: Quest (NYSE:DGX) And The Rest Of The Testing & Diagnostics Services Segment
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a... 
Via StockStory
News headline image
3 Cash-Producing Stocks That Fall Short
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff... 
Via StockStory
News headline image
3 Mid-Cap Stocks with Warning Signs
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man... 
Via StockStory
News headline image
3 Reasons to Avoid DGX and 1 Stock to Buy Instead
Since September 2025, Quest has been in a holding pattern, posting a small return of 4.5% while floating around $195.43. However, the stock is beating the S&... 
Via StockStory
News headline image
1 Healthcare Stock with Exciting Potential and 2 We Avoid
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva... 
Via StockStory
News headline image
The Great Migration: Outpatient Care Stocks Surge as Aging Populations and AI Reshape American Healthcare
As of March 17, 2026, the American healthcare landscape is undergoing its most significant structural transformation in decades. The traditional hospital-centric model is rapidly giving way to a... 
Via MarketMinute
Topics Artificial Intelligence
News headline image
5 Insightful Analyst Questions From Quest’s Q4 Earnings Call
Quest Diagnostics delivered a Q4 performance that exceeded Wall Street’s revenue and earnings expectations, prompting a positive market reaction. Management attributed this outcome to strong organic... 
Via StockStory
Topics Artificial Intelligence Earnings
News headline image
Quest Diagnostics (DGX): Navigating the New Frontier of Advanced Diagnostics and AI Efficiency
On February 11, 2026, the clinical laboratory landscape is recalibrating following a whirlwind 48 hours of financial and regulatory news. Quest Diagnostics (NYSE: DGX), the nation’s leading provider of... 
Via Finterra
Topics Artificial Intelligence
News headline image
DGX Q4 Deep Dive: Consumer Testing and Advanced Diagnostics Fuel Growth Amid Margin Headwinds
Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 7.1% year on year to $2.81 billion. The company’s... 
Via StockStory
Topics Artificial Intelligence
News headline image
Why Is Quest (DGX) Stock Soaring Today
Shares of healthcare diagnostics company Quest Diagnostics (NYSE:DGX) jumped 6.8% in the afternoon session after the company reported strong fourth-quarter financial results and offered an upbeat... 
Via StockStory
What's going on in today's session: S&P500 movers ↗
Via Chartmill
News headline image
Quest Diagnostics Stock Smashes 52-Week High On Strong Quarter, Dividend Hike ↗
Quest Diagnostics (NYSE: DGX) reported Q4 earnings of $2.42 per share, beating expectations. Sales were $2.81B, up 7.1% YoY. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.